NGS
NGS & Bioinformatics
NGS pipelines, informatics architecture, variant detection, indels, RNA and DNA analysis, long-read sequencing, isoforms, and practical interpretation.
Harvard Molecular Diagnostics Current Roles in Cancer Diagnosis 2026
Original price was: $900.97.$149.97Current price is: $149.97.
Original price was: $900.97.$149.97Current price is: $149.97.
Original price was: $1,199.00.$169.97Current price is: $169.97.
Original price was: $1,500.00.$99.97Current price is: $99.97.
Original price was: $1,475.97.$179.97Current price is: $179.97.
Original price was: $900.97.$99.97Current price is: $99.97.
Original price was: $1,395.00.$149.97Current price is: $149.97.
Total: $149.97
Immediate access to your resources, enabling you to start your learning journey without delay.
At ChidoPhysio, we guarantee affordability. Our prices are always up to 80% lower than other providers, ensuring you receive top-quality Physical therapy books without breaking the bank.
At ChidoPhysio, our dedicated customer support team is here to assist you every step of the way 24/7 . Your questions and concerns are our top priority.
Rest easy knowing that your payment is secure and encrypted when you choose to purchase our dental education resources. We offer trusted payment options, including PayPal and Stripe, to safeguard your financial information. Your privacy and security are our top priorities.
Description
HARVARD • MOLECULAR ONCOLOGY • 2026
Molecular Diagnostics: Current Roles in Cancer Diagnosis 2026
A comprehensive recorded molecular oncology program covering next-generation sequencing, bioinformatics, liquid biopsy, gene fusions, molecular biomarkers, tumor-specific testing, laboratory implementation, and precision cancer care.
40 RECORDED VIDEOS
40 ENGLISH SUBTITLES
41 PDF RESOURCES
INSTANT ACCESS
LIFETIME ACCESS
2026 Molecular Oncology Update
Next-Generation SequencingPipelines, indels, RNA/DNA analysis and long-read sequencing
Liquid Biopsy & ctDNATissue vs liquid testing and circulating tumor DNA
BiomarkersTMB, MSI, HRD, CNV and molecular signatures
Gene FusionsDetection, interpretation and oncogenicity assessment
Tumor-Specific TestingSolid tumors and hematologic malignancies
Clinical IntegrationReporting, reimbursement, regulation, AI and lab leadership
40Recorded Videos
40English Subtitles
41PDF Resources
5.47 GBComplete Package
About the Course
Translate modern molecular testing into practical cancer diagnosis and treatment decisions.
This three-day recorded program connects molecular laboratory methods with real clinical oncology, pathology, and precision-medicine workflows.
Molecular Diagnostics: Current Roles in Cancer Diagnosis 2026 provides a clinically focused introduction to modern molecular diagnostics for pathologists, oncologists, laboratory geneticists, and other professionals involved in cancer care.
The program reviews next-generation sequencing pipelines, informatics architecture, gene fusion detection, liquid biopsy, circulating tumor DNA, tumor mutational burden, microsatellite instability, homologous recombination deficiency, copy-number analysis, cytogenomics, methylation profiling, germline testing, and tumor-normal paired sequencing.
Tumor-specific sessions span sarcoma, gynecologic and pediatric tumors, genitourinary cancers, gliomas, melanoma, breast, lung, gastrointestinal, thyroid and salivary tumors, leukemia, lymphoma, and myeloid neoplasms — with additional attention to AI, pharmacogenomics, program building, reimbursement, and laboratory leadership.
Why clinicians choose this program
Comprehensive review of modern molecular oncology
Practical NGS and bioinformatics workflows
RNA- and DNA-based gene fusion testing
Liquid biopsy and ctDNA interpretation
Tumor-specific testing across major cancer types
Laboratory implementation, regulation and reimbursement
Core Learning Areas
From sequencing technology to precision oncology decisions.
The curriculum combines technical molecular methods, disease-specific applications, interpretation, communication, and implementation.
BIO
Biomarkers & Liquid Biopsy
Tumor mutational burden, MSI, HRD, copy-number variation, viral signatures, circulating tumor DNA, tissue-versus-liquid testing, and molecular residual disease concepts.
TMR
Tumor-Specific Diagnostics
Molecular testing in sarcoma, breast, lung, GI, GU, gynecologic, pediatric, thyroid, salivary, CNS, melanoma, leukemia, lymphoma, and myeloid neoplasms.
LAB
Clinical & Laboratory Integration
Tumor boards, report communication, pharmacogenomics, AI, program development, reimbursement, regulation, access, test selection, and laboratory leadership.
Course Directors
Meet the official 2026 course leadership.
Harvard lists Alanna Church, Lynette Sholl, and Valentina Nardi as Course Directors for Molecular Diagnostics: Current Roles in Cancer Diagnosis.
Course Director
Alanna Church, MD, MS
Associate Professor, Harvard Medical School
Director of Innovation in Pediatric Cancer Genomics
Associate Director, Laboratory for Molecular Pediatric Pathology
Program Director, Harvard Molecular Genetic Pathology Fellowship
Course Director
Lynette Sholl, MD
Professor of Pathology, Harvard Medical School
Chief, Pulmonary Pathology Division
Division Chief of Molecular Diagnostics, Mass General Brigham
Course Director
Valentina Nardi, MD
Associate Professor of Pathology, Harvard Medical School
Associate Director of Hematological Molecular Pathology, Mass General Brigham
Hematopathology and gene-fusion diagnostics
Additional Course Faculty
3-Day Curriculum
A structured progression from NGS and bioinformatics to tumor-specific testing and laboratory implementation.
A concise overview of the official 2026 three-day program.
NGS, Bioinformatics, Gene Fusions & Liquid Biopsy
- Integrated molecular oncology in 2026
- Next-day NGS workflows
- Molecular-to-immunohistochemistry translation
- Informatics architecture
- Practical NGS bioinformatics
- TMB, MSI and HRD
- Indel detection
- RNA-based gene-fusion testing
- Long-read sequencing
- Liquid biopsy and ctDNA
Solid Tumor Molecular Diagnostics
- Sarcoma and fusion testing
- Gynecologic tumors
- Pediatric tumors
- Genitourinary cancer markers
- Copy-number variation
- Cytogenomics
- Gliomas and methylation profiling
- Germline testing in oncology
- Tumor-normal paired sequencing
- Melanoma and breast cancer
- Tumor-board case review
Hematologic Malignancies, AI & Laboratory Leadership
- Myeloid neoplasms and MRD testing
- Leukemia molecular diagnostics
- Lymphoma molecular diagnostics
- Pharmacogenomics in oncology
- Lung and GI cancer testing
- Thyroid and salivary tumor genomics
- AI in molecular oncology
- Case-report writing and communication
- Building a profiling program
- Regulatory and reimbursement essentials
- Laboratory leadership and future directions
Who should take this course?
Designed for clinicians and laboratory professionals involved in cancer diagnosis, molecular testing, precision oncology, and multidisciplinary cancer care.
Course Package
The complete recorded 2026 program is organized for convenient self-paced review.
40
Recorded Videos
Recorded molecular-diagnostics sessions across the full three-day curriculum.
40
English Subtitles
Subtitle files supporting easier review of the recorded lectures.
41
PDF Resources
Downloadable educational materials for reference and structured review.
5.47 GB
Complete Package
Compact recorded learning package with lifetime access after purchase.
Frequently Asked Questions
Before you download.
Clear answers to common buyer questions.
Is this a live course?
No. This product contains recorded, on-demand educational materials for independent study.
What is included in the course package?
The package includes 40 recorded videos, 40 English subtitle files, and 41 PDF educational resources.
Does the course cover NGS and bioinformatics?
Yes. The curriculum includes NGS pipelines, informatics architecture, indel detection, RNA and DNA analysis, long-read sequencing, clinically significant isoforms, and practical bioinformatics.
Does it cover liquid biopsy and ctDNA?
Yes. Liquid biopsy, circulating tumor DNA, tissue-versus-liquid testing, and related molecular biomarker concepts are included.
Which cancer types are discussed?
The course includes molecular diagnostics for sarcoma, breast, lung, gastrointestinal, genitourinary, gynecologic, pediatric, thyroid, salivary, CNS, melanoma, leukemia, lymphoma, and myeloid malignancies.
How will I receive access after purchase?
Access instructions are provided after your order is completed so you can begin reviewing the available course materials right away.
Does course access expire?
No. The available recorded course package is provided with lifetime access.
Does this recorded package include CME/CE credit or a certificate?
No. The recorded package offered here does not include CME/CE credit or an official certificate.
Important:
This product provides recorded, on-demand educational materials and is not
registration for the original live Harvard event. No CME/CE credit or official
certificate is included with this recorded package.
MOLECULAR DIAGNOSTICS • PRECISION ONCOLOGY • 2026
Build a stronger practical framework for modern molecular cancer diagnostics.
Review next-generation sequencing, bioinformatics, liquid biopsy, gene fusions, molecular biomarkers, tumor-specific testing, AI, regulation, reimbursement, laboratory leadership and precision oncology — at your own pace.
DOWNLOAD COURSE NOWYou must be logged in to post a review.
Ebooks related to this title
-
PDF
Pediatric Hematology & Oncology Secrets 2nd Edition
Original price was: $71.89.$27.89Current price is: $27.89. Add to cart -
PDF
2025 ACP Internal Medicine Board Review Course – Greater Chicago, IL
Original price was: $1,495.00.$149.97Current price is: $149.97. Add to cart -
PDF
ACP CME 165 2025
Original price was: $1,500.00.$169.97Current price is: $169.97. Add to cart
Reviews
There are no reviews yet.